[Do serial ANCA titres predict relapse in ANCA-associated vasculitis?]

Area of Science:

• Immunology
• Rheumatology
• Nephrology

Context:

• Antineutrophil cytoplasm autoantibodies (ANCA) are key diagnostic markers for small-vessel vasculitis.
• The predictive value of ANCA for disease relapse remains debated, with conflicting evidence.
• Current research utilizes diverse methodologies and definitions, hindering consistent interpretation.

Purpose:

• To evaluate the existing evidence regarding the utility of ANCA in predicting relapse of small-vessel vasculitis.
• To highlight the need for standardized approaches in ANCA detection and interpretation for relapse prediction.
• To identify gaps in current research concerning the prognostic role of ANCA.

Summary:

• ANCA are essential for diagnosing small-vessel vasculitis.
• Evidence on ANCA's ability to predict relapse is contradictory.
• There is a need for multinational, multicentric prospective studies with uniform definitions and advanced ANCA detection tools.

Impact:

• Improved understanding of ANCA's prognostic value in vasculitis.
• Standardization of ANCA detection and interpretation could enhance clinical decision-making.
• Future research directions for clarifying ANCA's role in disease monitoring and management.